IL13 and hepatocellular carcinoma: In cases of HCC associated with MASLD-related cirrhosis, patients exhibited higher levels of fecal calprotectin and plasma levels of IL-8, IL-13, CCL3, CCL4, and CCL5 compared to those with MASLD-induced cirrhosis without HCC.